Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone

Transplantation Proceedings

Volumn 33, Issue 5, 2001, Pages 2776-2777

  Khauli, R B ^a   Medawar, W A ^b   Habbal, A A ^b   Birbari, A E ^b   Daouk, M M ^b   Abdelnoor, A M ^b   Uwaydah, M ^b   Bizri, A Rahman ^b   Sanjad, S ^b   Ayvazian, P J ^b   Lovewell, T ^b   Stoff, J S ^b   Fan, P Yang ^b   Bigwood, P ^b   Harland, R ^b  

^a Transplantation Unit   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAFT SURVIVAL; HUMAN; INFECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETREATMENT; RISK;

ACUTE DISEASE; ACYCLOVIR; ANTIVIRAL AGENTS; CADAVER; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; EMULSIONS; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MUROMONAB-CD3; MYCOPHENOLIC ACID; PREDNISONE; REOPERATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034898971     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02187-X     Document Type: Conference Paper

References (3)

1. Khauli RB, Wilson JM, Baker SP, et al: J Urology 153:1805, 1995
2. Sollinger HW: Transplantation 61:1029, 1996
3. European Mycophenolate Mofetil Cooperative Study Group: Lancet 345:1321, 1995